Osaic Holdings’s Albireo Pharma Inc ALBO Stock Holding History

Osaic Holdings’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-972	Closed	-$40.8K	–	7659
2022 Q4	$19.8K	Buy	972 +147	+18%	+$3.11K	﹤0.01%	5589
2022 Q3	$16K	Buy	825 +4	+0.5%	+$83	﹤0.01%	5773
2022 Q2	$16K	Sell	821 -747	-48%	-$19.7K	﹤0.01%	5791
2022 Q1	$46K	Sell	1,568 -676	-30%	-$19.8K	﹤0.01%	5165
2021 Q4	$52K	Buy	2,244 +60	+3%	+$1.59K	﹤0.01%	5122
2021 Q3	$68K	Buy	2,184 +2,087	+2,152%	+$64.6K	﹤0.01%	4871
2021 Q2	$4K	Buy	97 +11	+13%	+$358	﹤0.01%	6538
2021 Q1	$3K	Buy	86 +37	+76%	+$1.37K	﹤0.01%	6434
2020 Q4	$2K	Buy	+49	New	+$1.78K	﹤0.01%	6133

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Osaic Holdings's ALBO Position: Q1 2023 in Review

Osaic Holdings sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 972 shares — an estimated $40.8K sold.

Osaic Holdings first reported a position in ALBO in Q4 2020 and held it in 9 quarters. The position peaked at $68K in Q3 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Osaic Holdings reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Osaic Holdings sold 972 Albireo Pharma Inc shares in Q1 2023, an estimated $40.8K.
Osaic Holdings first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 9 quarters.
Osaic Holdings's Albireo Pharma Inc position peaked at $68K in Q3 2021.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.